Bellevue Healthcare Financials
| BBH Stock | 149.60 2.32 1.58% |
Return On Equity 15.8082 |
Bellevue | Select Account or Indicator |
Understanding current and past Bellevue Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bellevue Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Bellevue Healthcare's assets may result in an increase in income on the income statement.
Please note, the presentation of Bellevue Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bellevue Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bellevue Healthcare's management manipulating its earnings.
Bellevue Healthcare Stock Summary
Bellevue Healthcare competes with Kroger, International Business, Neometals, SANTANDER, and Coor Service. Bellevue Healthcare is entity of United Kingdom. It is traded as Stock on LSE exchange.| Foreign Associate | USA |
Specialization | Financial Services, Financial Services |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| ISIN | GB00BZCNLL95 |
| Business Address | Seestrasse 16, Kusnacht, |
| Sector | Capital Markets |
| Industry | Financials |
| Benchmark | Dow Jones Industrial |
| Website | www.bbhealthcaretrust.com/en/bb-healthcare |
| Phone | 41 44 267 67 00 |
You should never invest in Bellevue Healthcare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bellevue Stock, because this is throwing your money away. Analyzing the key information contained in Bellevue Healthcare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Bellevue Healthcare Key Financial Ratios
There are many critical financial ratios that Bellevue Healthcare's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bellevue Healthcare Trust reports annually and quarterly.| Revenue | (119.25 M) | |||
| EBITDA | (120.88 M) | |||
| Net Income | (121.04 M) | |||
| Total Asset | 808 M | |||
| Retained Earnings | (2.44 M) |
Bellevue Healthcare Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 848.5M | 1.1B | 1.1B | 808.0M | 929.2M | 840.8M | |
| Other Current Liab | (4.6M) | (67.9M) | (83.7M) | (31.7M) | (28.5M) | (30.0M) | |
| Net Debt | (92.8M) | 39.9M | 37.4M | (79.3M) | (71.3M) | (67.8M) | |
| Retained Earnings | 420K | 777K | (1.3M) | (2.4M) | (2.2M) | (2.1M) | |
| Accounts Payable | 4.6M | 9.3M | 1.9M | 26K | 29.9K | 28.4K | |
| Cash | 92.8M | 28.0M | 46.4M | 111.0M | 127.6M | 134.0M | |
| Other Assets | 107K | 167K | 392K | 111K | 99.9K | 94.9K | |
| Total Liab | 4.6M | 78.3M | 86.6M | 142.5M | 163.8M | 172.0M | |
| Total Current Assets | 95.0M | 28.0M | 47.2M | 111.0M | 127.6M | 134.0M | |
| Common Stock | 4.9M | 5.6M | 5.9M | 4.6M | 5.3M | 4.9M | |
| Capital Stock | 4.9M | 5.6M | 5.9M | 4.6M | 5.3M | 5.2M |
Bellevue Healthcare Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 529K | 659K | 285K | 157K | 180.6K | 171.5K | |
| Net Interest Income | (809K) | (489K) | (2.7M) | (2.0M) | (1.8M) | (1.9M) | |
| Interest Income | 134K | 0.0 | 283K | 1.5M | 1.8M | 1.9M | |
| Interest Expense | 943K | 489K | 3.0M | 3.5M | 4.0M | 4.2M | |
| Total Revenue | 159.6M | 89.2M | (40.0M) | (119.3M) | (107.3M) | (102.0M) | |
| Gross Profit | 159.6M | 89.2M | (40.0M) | (119.3M) | (107.3M) | (102.0M) | |
| Operating Income | 158.5M | 87.9M | (38.2M) | (120.9M) | (108.8M) | (103.4M) | |
| Ebitda | 158.5M | 87.9M | (38.2M) | (120.9M) | (108.8M) | (103.4M) | |
| Income Before Tax | 158.5M | 87.9M | (41.1M) | (120.9M) | (108.8M) | (103.4M) | |
| Net Income | 158.0M | 87.3M | (41.4M) | (121.0M) | (108.9M) | (103.5M) | |
| Income Tax Expense | 529K | 659K | 285K | 157K | 180.6K | 171.5K |
Bellevue Healthcare Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Bellevue Healthcare Trust. It measures of how well Bellevue is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Bellevue Healthcare brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Bellevue had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Bellevue Healthcare has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 33.1M | (64.8M) | 18.4M | 64.6M | 74.3M | 78.0M | |
| Free Cash Flow | (2.8M) | (8.5M) | (41.4M) | (6.5M) | (7.5M) | (7.9M) | |
| Other Non Cash Items | (42.8M) | (158.0M) | (87.3M) | 41.4M | 47.6M | 50.0M | |
| Dividends Paid | 22.3M | 29.3M | 36.5M | 34.2M | 39.3M | 24.1M | |
| Net Income | 158.0M | 87.3M | (41.4M) | (121.0M) | (108.9M) | (103.5M) | |
| End Period Cash Flow | 92.8M | 28.0M | 46.4M | 111.0M | 127.6M | 134.0M | |
| Investments | 33.1M | (224.6M) | 11.5M | 230.6M | 265.2M | 278.5M |
Bellevue Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bellevue Healthcare's current stock value. Our valuation model uses many indicators to compare Bellevue Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bellevue Healthcare competition to find correlations between indicators driving Bellevue Healthcare's intrinsic value. More Info.Bellevue Healthcare Trust is number one stock in return on equity category among its peers. It also is number one stock in shares outstanding category among its peers creating about 34,712,427 of Shares Outstanding per Return On Equity. As of August 2, 2024, Common Stock Shares Outstanding is expected to decline to about 444.5 M. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bellevue Healthcare's earnings, one of the primary drivers of an investment's value.Bellevue Healthcare Trust Systematic Risk
Bellevue Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bellevue Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Bellevue Healthcare Trust correlated with the market. If Beta is less than 0 Bellevue Healthcare generally moves in the opposite direction as compared to the market. If Bellevue Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bellevue Healthcare Trust is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bellevue Healthcare is generally in the same direction as the market. If Beta > 1 Bellevue Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Bellevue Healthcare Trust Total Assets Over Time
Bellevue Healthcare Thematic Clasifications
Bellevue Healthcare Trust is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas
| Health Management | View |
Bellevue Healthcare August 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bellevue Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bellevue Healthcare Trust. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bellevue Healthcare Trust based on widely used predictive technical indicators. In general, we focus on analyzing Bellevue Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bellevue Healthcare's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.982 | |||
| Information Ratio | 0.0663 | |||
| Maximum Drawdown | 5.63 | |||
| Value At Risk | (1.26) | |||
| Potential Upside | 1.71 |
Complementary Tools for Bellevue Stock analysis
When running Bellevue Healthcare's price analysis, check to measure Bellevue Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellevue Healthcare is operating at the current time. Most of Bellevue Healthcare's value examination focuses on studying past and present price action to predict the probability of Bellevue Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bellevue Healthcare's price. Additionally, you may evaluate how the addition of Bellevue Healthcare to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |